PR Newswire - World's First | Mabwell's 9MW5211 Receives FDA Cle...
SHANGHAI, May 9, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Investigational New Drug ...
Read More

ภาษาไทย
English